LPL Financial’s Kindred Biosciences, Inc. KIN Stock Holding History

LPL Financial’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-13,244	Closed	-$68K	–	2834
2016 Q4	$68K	Sell	13,244 -431	-3%	-$2.09K	﹤0.01%	2619
2016 Q3	$70K	Sell	13,675 -250	-2%	-$1.06K	﹤0.01%	2560
2016 Q2	$52K	Sell	13,925 -14,425	-51%	-$53K	﹤0.01%	2558
2016 Q1	$102K	Sell	28,350 -1,576	-5%	-$5.57K	﹤0.01%	2941
2015 Q4	$107K	Buy	29,926 +14,190	+90%	+$65.8K	﹤0.01%	2975
2015 Q3	$80K	Sell	15,736 -2,007	-11%	-$12.4K	﹤0.01%	2678
2015 Q2	$122K	Sell	17,743 -251	-1%	-$1.78K	﹤0.01%	2732
2015 Q1	$124K	Buy	17,994 +3,400	+23%	+$23.4K	﹤0.01%	2651
2014 Q4	$109K	Buy	14,594 +836	+6%	+$7.09K	﹤0.01%	2616
2014 Q3	$128K	Buy	+13,758	New	+$186K	﹤0.01%	2575

Other funds holding KIN

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

AFS

Amtrust Financial Services New York $300M AUM 12.98% 1-Year Est. Return

LPL Financial's KIN Position: Q1 2017 in Review

LPL Financial sold out of Kindred Biosciences, Inc. (KIN) in Q1 2017, closing a stake of 13,244 shares — an estimated $68K sold.

LPL Financial first reported a position in KIN in Q3 2014 and held it in 10 quarters. The position peaked at $128K in Q3 2014. 48 funds tracked by Wall St. Rank hold KIN as of Q1 2017.

LPL Financial reported no remaining Kindred Biosciences, Inc. position as of Q1 2017 after selling out during the quarter.
LPL Financial sold 13,244 Kindred Biosciences, Inc. shares in Q1 2017, an estimated $68K.
LPL Financial first reported a position in Kindred Biosciences, Inc. in Q3 2014 and held it in 10 quarters.
LPL Financial's Kindred Biosciences, Inc. position peaked at $128K in Q3 2014.
48 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q1 2017.

Based on LPL Financial's 13F filing for Q1 2017, filed 15 May 2017.